There is currently no standardised approach to identifying and following up high-risk newborns, including those with a prenatal diagnosis of congenital abnormality. High-risk newborns are at risk of poor health and delayed developmental outcomes. Early intervention is key to support infants and families, yet there remains a disconnect between research and clinical practice.
One in seven women experience postnatal depression, yet only 10 percent receive adequate treatment. Postnatal depression screening is mainly conducted by time-poor Maternal & Child Health Nurses (MCHNs) who are not mental health specialists and receive limited clinical guidance for ongoing management and referrals. Current paper-and-pencil procedures are inconsistent and error-prone.